Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.
Bottom Line: To date, pain management strategies have failed to alleviate these symptoms, hence development of adapted analgesics is needed.Mechanistically, oxaliplatin promotes over-excitability by drastically lowering the expression of distinct potassium channels (TREK1, TRAAK) and by increasing the expression of pro-excitatory channels such as the hyperpolarization-activated channels (HCNs).The translational and clinical implication of these findings would be that ivabradine may represent a tailored treatment for oxaliplatin-induced neuropathy.
Affiliation: Département de Physiologie, CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France.Show MeSH
Related in: MedlinePlus
Mentions: One of the most marked transcript expression changes observed was a decrease in background potassium channels. Consequently, we asked whether oxaliplatin-induced cold hypersensitivity would still develop in mice invalidated for both TREK1 and TRAAK subunits. As presented in Fig 7A and B, vehicle-treated TREK1-TRAAK KO animals presented a tonic intolerance to noxious cold (Fig 7A) and cool allodynia (Fig 7B) similar to that of wild type animals after oxaliplatin treatment (Fig 1B and D). Interestingly, oxaliplatin failed to increase this tonic hypersensitivity to cold in the double KO mice, demonstrating a total loss of oxaliplatin modulation of cold perception in this genotype in agreement with the qPCR results. As previously described, the TREK1-TRAAK KO mice presented a robust mechanical hyperalgesia that could not be further modified by oxaliplatin (Fig 7C).
Affiliation: Département de Physiologie, CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France.